Feb. 19, 2016

Details: St. Jude Medical announced that its Axium neurostimulator has been approved by the FDA to help treat moderate to severe chronic intractable pain of the lower limbs in adults with complex regional pain syndrome (CRPS I and II) by stimulating the dorsal root ganglion (DRG). The DRG is an interesting target to stimulate electrically due its location.

Visit: http://feedproxy.google.com/~r/Medgadget/~3/P_H7Fw7cCqE/st-jude-medicals-axium-drg-stimulator-approved-by-fda-for-comple …

Advertisements